Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.46 |
| ▸ | GHSR | Q92847 | 8/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29653453 | 0.91 | SLC15A2 (0.44) | SLC15A2GHSR | |
| SCHEMBL30834755 | 0.91 | SLC15A2 (0.44) | SLC15A2GHSR | |
| SCHEMBL31188427 | 0.89 | SLC15A2 (0.40) | SLC15A2GHSR | |
| SCHEMBL29613332 | 0.88 | SLC15A2 (0.40) | SLC15A2GHSR | |
| SCHEMBL5884470 | 0.88 | SLC15A2 (0.51) | SLC15A2GHSR | |
| SCHEMBL31453801 | 0.88 | SLC15A2 (0.51) | SLC15A2GHSR | |
| SCHEMBL29849009 | 0.88 | SLC15A2 (0.51) | SLC15A2GHSR | |
| SCHEMBL5884458 | 0.88 | SLC15A2 (0.51) | SLC15A2GHSR | |
| SCHEMBL5598772 | 0.87 | ERAP2 (0.48) | SLC15A2 | |
| SCHEMBL5598767 | 0.87 | ERAP2 (0.48) | SLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137691-A1 | WB3 FOR ANESTHESIA AND TREATING PAIN | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-05-21 | — | — | US | disclosed |
| US-12240816-B2 | Deuterated compounds and uses thereof | ALDEYRA THERAPEUTICS, INC. (US) | 2025-03-04 | — | — | US | disclosed |
| US-20240132451-A1 | DEUTERATED COMPOUNDS AND USES THEREOF | ALDEYRA THERAPEUTICS, INC. | 2024-04-25 | — | — | US | disclosed |
| EP-3337486-B1 | DEUTERATED COMPOUNDS AND USES THEREOF | ALDEYRA THERAPEUTICS INC (US) | 2024-04-03 | — | — | EP | disclosed |
| US-11845722-B2 | Deuterated compounds and uses thereof | ALDEYRA THERAPEUTICS, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| US-20230174491-A1 | DEUTERATED COMPOUNDS AND USES THEREOF | ALDEYRA THERAPEUTICS, INC. | 2023-06-08 | — | — | US | disclosed |
| US-11459300-B2 | Deuterated compounds and uses thereof | ALDEYRA THERAPEUTICS, INC. (US) | 2022-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137691-A1 | WB3 FOR ANESTHESIA AND TREATING PAIN | WNT3, TRPV3, ADRB3 | SLC15A2 1139/4885GHSR 3841/4885 |
| US-11845722-B2 | Deuterated compounds and uses thereof | ALDH1A2, SSB, DBH | SLC15A2 2554/4885GHSR 4003/4885 |
| US-20230174491-A1 | DEUTERATED COMPOUNDS AND USES THEREOF | ALDH1A2, SSB, DBH | SLC15A2 2554/4885GHSR 4003/4885 |
| US-12240816-B2 | Deuterated compounds and uses thereof | ALDH1A2, SSB, DBH | SLC15A2 2554/4885GHSR 4003/4885 |
| US-11459300-B2 | Deuterated compounds and uses thereof | ALDH1A2, SSB, DBH | SLC15A2 2554/4885GHSR 4003/4885 |
| US-20240132451-A1 | DEUTERATED COMPOUNDS AND USES THEREOF | ALDH1A2, SSB, DBH | SLC15A2 2554/4885GHSR 4003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.